-
Mar 2013
CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring.
ImmunologyYang J, James EA, Sanda S, Greenbaum CJ, Kwok WW -
Jan 2013
The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetes.
J Pediatr Endocrinol MetabCrume TL, Andrews JS, D'Agostino RB Jr, Pettitt DJ, Mayer-Davis EJ, Law JR, Dolan L, Lawrence JM, Saydah S, Greenbaum CJ, Rodriguez BL, Dabelea DM, SEARCH for Diabetes in Youth Study Group. -
Dec 2012
Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study.
DiabetologiaDabelea D, Mayer-Davis EJ, Andrews JS, Dolan LM, Pihoker C, Hamman RF, Greenbaum CJ, Marcovina SM, Fujimoto W, Linder B, Imperatore G, D'Agostino R Jr -
Jul 2012
Improvement in outcomes of clinical islet transplantation: 1999-2010.
Diabetes CareBarton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, Pattou F, Berney T, Secchi A, Messinger S, Senior PA, Maffi P, Posselt A, Stock PG, Kaufman DB, Luo X, Kandeel F, Cagliero E, Turgeon NA, Witkowski P, Naji A, O'Connell PJ, Greenbaum CJ, Kudva YC, Brayman KL, Aull MJ, Larsen C, Kay TWH, Fernandez LA, Vantyghem MC, Bellin MD, Shapiro AMJ -
May 2012
Perspective: Rethink the immune connection.
NatureGreenbaum CJ -
Mar 2012
Dead or alive?
Diabetes CareGreenbaum CJ -
Jan 2012
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience.
Rev Diabet StudEhlers MR, Nepom GT -
Dec 2011
Effect of rituximab on human in vivo antibody immune responses.
J Allergy Clin ImmunolPescovitz MD, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum CJ, Herold KC, Skyler JS, Weinberg A, Type 1 Diabetes TrialNet Study Group. -
Dec 2011
Making progress: preserving beta cells in type 1 diabetes.
Ann N Y Acad SciGallagher MP, Goland RS, Greenbaum CJ -
Jul 2011
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
LancetOrban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group. -
Jun 2011
Comment on: Atkinson. It's time to consider changing the rules: the rationale for rethinking control groups in clinical trials aimed at reversing type 1 diabetes. Diabetes 2011;60:361-363.
DiabetesSanda S, Greenbaum CJ -
Mar 2011
Persistence is the twin sister of excellence: an important lesson for attempts to prevent and reverse type 1 diabetes.
DiabetesGreenbaum CJ, Atkinson MA -
Aug 2010
Short-term IL-1beta blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes.
Clin ImmunolSanda S, Bollyky J, Standifer N, Nepom GT, Hamerman JA, Greenbaum CJ -
Apr 2010
Prediction and pathogenesis in type 1 diabetes.
ImmunityZiegler AG, Nepom GT -
Jan 2010
Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium.
Clin TrialsHall MA, King NM, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C, T1DGC.
